tenk.fyi

BioAtla, Inc.

BCABNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$59.6M

14.6% YoY

EPS

$-1.01

29.9% YoY

Cash

$7.1M

85.5% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro